氟比洛芬酯对肢体缺血—再灌注后患者动脉血气及炎性反应的影响(2)
表2 两组患者MAP、HR及血气肺功能指标(n=15,x±s)项目组别T0T1T2T3T4
MAP(mmHg)C组99.5±16.394.8±17.298.3±18.192.7±18.596.9±16.4
F组98.3±15.994.1±17.797.6±16.395.1±17.998.2±15.7
HR(次/min)C组69.3±12.671.2±14.272.2±13.571.9±15.670.4±11.6
F组70.4±13.572.5±13.872.6±16.170.8±14.171.3±12.7
PaO2(mmHg)C组91.7±7.190.1±8.687.5±12.379.9±8.6a89.6±10.2
F组90.9±8.391.8±7.988.9±10.181.1±9.2a88.8±9.4
PA-aDO2(mmHg)C组11.2±3.110.9±3.312.2±2.924.1±6.2a11.0±3.6
F组12.1±3.611.2±3.513.5±3.815.7±5.1ab12.1±4.1
RIC组0.15±0.030.14±0.020.17±0.030.39±0.10a0.19±0.06
F组0.15±0.030.15±0.030.16±0.020.29±0.07ab0.18±0.04
PaCO2(mmHg)C组35.1±3.137.2±4.536.9±2.937.1±4.536.9±4.1
F组36.4±3.336.9±3.836.8±3.236.6±4.136.8±3.6
Hb(mg/dL)C组11.8±1.111.9±1.211.8±1.711.5±0.911.7±0.7
F组11.7±1.612.0±1.411.7±1.811.6±1.211.6±1.1
注:与T0比较 ......
您现在查看是摘要页,全文长 3639 字符。